Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment
The Journal of Family Practice. 2017 October;66(10):
This supplement was sponsored by Primary Care Education Consortium and Primary Care Metabolic Group and was supported by funding from Novo Nordisk Inc.
October 2, 2017|Family Medicine
Click Here to Read the Supplement.
Topics include:
- Medications for Type 2 Diabetes Mellitus: A Work in Progress
- Role of Injectable Medications in Type 2 Diabetes Treatment
- Basal Insulins
- Glucagon-Like Peptide-1 Receptor Agonists
- Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist